Owner Sirtris Pharmaceuticals, Inc.

Inventors Milne, Jill; Nunes, Joseph J.; Vu, Chi B.; Ng, Pui Yee; Bemis, Jean; Xie, Roger; Disch, Jeremy S.

Agent Shelston IP

Pub. Number AU-A-2006278396

PCT Pub. Number WO2007/019416

Priority 60/741,783 02.12.05 US; 60/705,612 04.08.05 US; 60/779,370 03.03.06 US; 60/792,276 14.04.06 US

Filing date 4 August 2006

Wipo publication date 15 February 2007

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61K 31/435 (2006.01) - having six-membered rings with one nitrogen as the only ring hetero atom

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61P 7/00 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 21/00 (2006.01) Drugs for disorders of the muscular or neuromuscular system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 27/00 (2006.01) Drugs for disorders of the senses

A61P 35/00 (2006.01) Antineoplastic agents

C07D 235/18 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group